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miR-34a2/2 Mice are Susceptible to Diet-Induced Obesity
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Andrew Collier4, Andrew H. Baker1, and Ashley M. Miller1
Objective: MicroRNA (miR)234a regulates inflammatory pathways, and increased transcripts have been
observed in serum and subcutaneous adipose of subjects who have obesity and type 2 diabetes. There-
fore, the role of miR-34a in adipose tissue inflammation and lipid metabolism in murine diet-induced obe-
sity was investigated.
Methods: Wild-type (WT) and miR-34a2/2 mice were fed chow or high-fat diet (HFD) for 24 weeks. WT
and miR-34a2/2 bone marrow-derived macrophages were cultured in vitro with macrophage colony-stim-
ulating factor (M-CSF). Brown and white preadipocytes were cultured from the stromal vascular fraction
(SVF) of intrascapular brown and epididymal white adipose tissue (eWAT), with rosiglitazone.
Results: HFD-fed miR-34a2/2 mice were significantly heavier with a greater increase in eWAT weight
than WT. miR-34a2/2 eWAT had a smaller adipocyte area, which significantly increased with HFD. miR-
34a2/2 eWAT showed basal increases in Cd36, Hmgcr, Lxra, Pgc1a, and Fasn. miR-34a2/2 intrascapular
brown adipose tissue had basal reductions in c/ebpa and c/ebpb, with in vitro miR-34a2/2 white adipo-
cytes showing increased lipid content. An F4/80high macrophage population was present in HFD miR-
34a2/2 eWAT, with increased IL-10 transcripts and serum IL-5 protein. Finally, miR-34a2/2 bone marrow-
derived macrophages showed an ablated CXCL1 response to tumor necrosis factor-a.
Conclusions: These findings suggest a multifactorial role of miR-34a in controlling susceptibility to obe-
sity, by regulating inflammatory and metabolic pathways.
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Introduction
The growing incidence of obesity worldwide has presented new thera-
peutic challenges, making it critical to understand the underlying mech-
anisms of obesity-associated pathology. In 2014, the World Health
Organization estimated that 12.9% of adults have obesity (BMI
30 kg/m2, age 18 years) worldwide, with the Americas (26.8%)
and Europe (23%) showing the highest percentage. Obesity is associ-
ated with increased low-grade, chronic inflammation that predisposes
individuals to a number of comorbidities, e.g., type 2 diabetes (T2D),
dyslipidemia, cardiovascular diseases (CVDs), and cancers (1,2).
The main proponent of weight gain during obesity is white adipose
tissue (WAT). However, far from being just a lipid storage vessel,
WAT can modulate the inflammatory response through secretion of
inflammatory cytokines, including CCL2, CXCL8, tumor necrosis
factor (TNF)-a, interleukin (IL)21b, and IL-6 (1-3). In opposition,
brown adipose tissue (BAT) expends fatty acids (FA) to produce
heat through mitochondrial action and uncoupled protein 1 (UCP1),
maintaining body temperature. Peroxisome proliferator-activated
receptor (PPAR)-c coactivator (PGC)21a is important for BAT
adaptive thermogenesis, increasing mitochondrial biogenesis and
UCP1 expression and promoting brown adipocyte differentiation (4).
MicroRNAs (miRNAs/miRs) are small (19–25 nt), noncoding
RNAs, which primarily bind the 3’ untranslated region of target
mRNA, mediated by Argonaute proteins within the cytoplasmic
RNA-inducing silencing complex (RISC). Before RISC loading,
miRNAs form a duplex consisting of a mature (5p) and star (3p)
strand, but usually only the 5p is loaded. mRNA is silenced through
inhibition of translation or degradation (5).
The miR-34 family consists of 34a, 34b, and 34c, with miR-34a
encoded on chromosome 1p36.22 and miR-34b and c on chromo-
some 11q23.1 (6). Interestingly, miR-34a appears to be dysregulated
during obesity, with increased serum miR-34a transcripts found in
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patients who have excess weight (BMI 25 kg/m2) with T2D, com-
pared with patients who have excess weight without diabetes (7). In
addition, studies have shown a correlation with increasing BMI and
miR-34a transcripts in human subcutaneous WAT (scWAT) and
increased miR-34a transcripts over subcutaneous adipocyte differen-
tiation in vitro (8,9). Further to its pro-diabetes role, miR-34a tran-
scripts have been positively associated with destruction of primary
b-islet cells and cell lines, upon inflammatory stimulation, with
decreased insulin secretion, through inhibition of VAMP2 (10,11).
Inflammatory roles of miR-34a have been proposed, with
lipopolysaccharide-induced inflammation reducing miR-34a expres-
sion in macrophage cell lines, and miR-34a mimics reducing IL-6
and TNF-a expression (12). Furthermore, miR-34a has been shown
to target the soluble IL-6 receptor (13).
Adipose tissue macrophages (ATMs) represent a major immune infil-
trate into the obese WAT (predominantly visceral), increasing from
around 12% to 41% (14). Increasing inflammatory cytokines, particu-
larly CCL2, recruits monocytes into the WAT that differentiate into
ATMs (15). A high percentage are proinflammatory F4/801 CD11b1
CD11c1 M1 ATMs in high-fat diet (HFD)-fed rodents, and depletion of
these cells has shown a reversal in inflammation and insulin resistance
(16). Other immune cells, such as neutrophils, have also been shown to
contribute to insulin resistance and obesity-induced inflammation (17).
Therefore, the aims of this study were to examine the metabolic and
inflammatory role of miR-34a in a murine, diet-induced obesity
model, using miR-34a2/2 mice; specifically, examining miR-34a’s
role in adipocytes and macrophages during obesity. Our findings
show that miR-34a2/2 mice are susceptible to weight gain, likely
through basal metabolic gene changes in adipose caused by dysregu-
lation of PGC-1a.
Methods
Murine studies
All in vivo studies used 7-week-old, male, wild-type (WT) or miR-
34a2/2 (B6.Cg-Mir34atm1Lhe/J) C57BL/6 mice (Jackson Labs, Sacra-
mento, CA) bred in-house. Mice were fed normal chow (chow) or
HFD (0.15% cholesterol and 21% lard: Special Diet Services, Essex,
UK) ad libitum for 24 weeks. Weekly weights, monthly fasting
blood glucose, and glucose tolerance test (GTT) measurements were
recorded. Fasting (16–18 h) blood glucose measurements were
recorded using an Accu-ChekVR Mobile glucose monitor (Roche,
Burgess Hill, UK: Model U1; Max: 33.33 mmol/L). GTT measure-
ments were taken every 30 min, following I.P. administration of
1 g/kg glucose, in 0.9% saline solution. All studies were carried out
in a registered research facility, under UK Home Office guidelines.
Human studies
Omental adipose tissue biopsies were collected from six patients
with obesity (five women and one man), T2D (HbA1c5 7.56
0.97%), and/or sleep apnea, undergoing bariatric surgery. Patients
were on metformin (BMI: 42.136 3.24; age: 50.176 8.08 years).
All patients gave written informed consent before inclusion in the
study, with approval from the West of Scotland Research Ethics
Service (REC Ref 12/WS/0158).
Additional methods can be found in Supporting Information.
Results
Expression of miR-34a in obese adipose tissue
and in vitro bone marrow-derived macrophages
In situ hybridization showed miR-34a distribution within visceral
WAT was ubiquitous throughout the epididymal (e)WAT of WT
mice on chow and HFD and omental adipose from bariatric surgery
patients with obesity (Figure 1A). Similarly, no change was observed
in miR-34a or miR-34a* transcripts between WT chow and HFD
groups (Figure 1B). However, we observed increases in both miR-34a
and 34a* transcripts within the liver (P 5 0.0088, P 5 0.0247) and
intrascapular (i)BAT (P 5 0.0433, P 5 0.0399) during HFD feeding
(Figure 1C). Furthermore, we observed an increase in miR-34a (P 5
0.0086) and miR-34a* (P 5 0.0461) transcripts in WT bone marrow-
derived macrophages (BMDMs) when stimulated with TNF-a (Figure
1D). We examined the other miR-34 family members but found no
expression changes (Supporting Information Figure S1).
Endogenous miR-34a regulated body weight and
adipocyte size
To investigate the role of endogenous miR-34a in regulating obesity,
we measured the weight and metabolic parameters of WT and miR-
342/2 mice over 24 weeks on chow or HFD (Figure 2A). Before the
study began, it was noted that miR-342/2 mice were heavier at week
0 (chow: 6.71%; P 5 0.1311 and HFD: 8.07%; P 5 0.0377) (Sup-
porting Information Figure S2A). This was maintained in the chow
group at week 2 (6.11%; P 5 0.0312) and 3 (6.86%; P 5 0.0798)
but increased further in HFD-fed miR-342/2 mice at week 2 (12%; P
< 0.0001) and 3 (11.60%; P 5 0.0009). HFD-fed miR-34a2/2 mice
were significantly heavier (9.226 0.56%; P 5 0.0075) than WT
counterparts over 24 weeks, by AUC analysis (Figure 2B, C). Body
weights of chow-fed miR-34a2/2 mice were similar to WT controls.
Interestingly, when we examined the total body fat percentage
(AUClipid) by MRS, both HFD-fed WT and miR-34a
2/2 mice showed
similar fat content (41.76 1.04% vs. 43.56 0.68%) (Figure 2D).
These weight differences were not explained by food intake during
metabolic cage studies (Supporting Information Figure S2B) or fasting
serum leptin levels (Supporting Information Figure S2C).
However, ex vivo investigations revealed a significant increase in
eWAT weight in HFD-fed miR-34a2/2 mice (0.616 0.10 g to
1.806 0.08 g; P < 0.0001) not observed in WT controls (Figure
2e). Liver weight remained unchanged (Supporting Information Fig-
ure S2D). Histological examination of the eWAT revealed smaller,
more densely packed adipocytes within the miR-34a2/2 chow tis-
sues, compared with WT (Figure 2F, G). When stressed with a
HFD, the eWAT from miR-34a2/2 mice showed a significant
increase in cell area (P 5 0.0030) and decrease in cell number per
field (P 5 0.0013) not seen in WT, bringing them to WT levels.
To examine alterations in glucose homeostasis, we measured
monthly fasting blood glucose and performed a GTT at week 24.
However, we did not observe any changes between HFD-fed WT
and miR-34a2/2 mice, both showing hyperglycemia from week 12
(P < 0.001) (Supporting Information Figure S2E) and similar glu-
cose handling (Supporting Information Figure S2F). This was further
compounded by no change in fasting serum insulin or resistin
between HFD groups at week 24 (Supporting Information Figure
S2F). Additionally, there was no change in fasting serum cholesterol
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and triglyceride measurements between WT and miR-34a2/2 groups
on either chow or HFD (Supporting Information Table S1).
miR-34a2/2 mice showed basal metabolic gene
changes in eWAT and iBAT on chow diet
To investigate the changes in adipose weight and adipocyte size, we
examined metabolic gene expression in eWAT ex vivo. The following
FA and cholesterol metabolism genes’ expression was increased in
chow-fed miR-34a2/2 mice compared with WT chow counterparts:
Cd36 (P 5 0.0036), 3-hydroxy-3-methyl-glutaryl-CoA reductase
(Hmgcr; P 5 0.0012), liver X receptor (Lxra; P 5 0.0034), Pgc-1a
(P 5 0.0138), and fatty acid synthase (Fasn; P 5 0.0027). In addi-
tion, decreased Ppar-c (P 5 0.0471), acetyl-CoA carboxylase (Acc-a;
P 5 0.0018), and Fasn (P 5 0.0274) transcripts were observed in
miR-34a2/2 mice when fed HFD (Figure 3A). We observed no
Figure 1 Expression of miR-34a in adipose tissue. (A) In situ hybridization (ISH) images of miR-34a expression (purple) compared with a Scramble (Scr; red)
negative control in epididymal (e)WAT from WT mice fed chow or high-fat diet (HFD) for 24 weeks and omental adipose from patients with obesity under-
going bariatric surgery. RT-qPCR data showing expression of miR-34a and 34a* in (B) eWAT and (C) liver and intrascapular (i)BAT collected from WT mice
24 weeks after commencing a chow vs. HFD. (D) RT-qPCR quantification of miR-34a and 34a* transcripts in WT in vitro bone marrow-derived macro-
phages (BMDM)645.45 ng/mL tumor necrosis factor (TNF)-a for 24 h. Data represented as relative quantification (RQ) with RQmin2RQmax values, normal-
ized to RNU6; n5 3–4 for eWAT, n5 5–6 for liver, n 5 6 for iBAT, and n 5 3 for BMDMs. *P < 0.05, **P < 0.01, unpaired Student’s t-test.
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Figure 2 miR-34a2/2 mice are susceptible to diet-induced obesity. (A) Diagrammatic representation of the 24-week in vivo study
structure: high-fat diet (HFD), fasting blood glucose (FBG), and glucose tolerance test (GTT). Data in panels B–F are from WT and
miR-34a2/2 (KO) mice on chow vs. HFD over 24 weeks of diet. (B) Representative image of HFD-fed WT and KO mice at week 24
of study. (C) Body weight measurements over 24 weeks; n 5 10 for KO chow and WT HFD and n 5 9 for WT chow and KO HFD
groups. (D) MRS analysis of mouse percentage body fat at week 24, calculated from integration ratios for lipid (AUClipid) to water
(AUCH2O) peaks; n 5 6 for WT chow and HFD, n 5 4 for KO HFD, and n 5 3 for chow HFD groups. (E) Weight of excised epididy-
mal (e)WAT at week 24 of study; n 5 10 for KO chow and WT HFD and n 5 9 for WT chow and KO HFD groups. (F) Representative
H&E staining of eWAT excised in panel E. (G) Quantification of adipocyte area and number in panel F, with averages taken from 5
fields per section of n 5 10 for KO chow and WT HFD and n 5 8 for WT chow and KO HFD groups. Area measurements were con-
verted from pixels to square centimeters using the image scale. All graphs represent mean values with SEM. **P < 0.01, ****P <
0.0001, one-way ANOVA, with Bonferroni’s multiple comparisons post-test.
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changes in other eWAT metabolic genes examined (Supporting Infor-
mation Figure S3A).
Furthermore, we investigated the expression of metabolic genes in
iBAT. Interestingly, we observed decreased expression of Cebpa (P
< 0.01) and Cebpb (P < 0.01) from both miR-34a2/2 groups and
increased expression of Pgc1a (P 5 0.0072) in miR-34a2/2 mice
when fed HFD (Figure 3B). However, Ucp1 expression remained
unchanged. Additionally, we saw few changes in hepatic metabolic
genes (Supporting Information Figure S3B–D).
eWAT macrophages from HFD-fed miR-34a2/2
mice expressed an F4/80high phenotype, with an
increase in type 2 cytokines
Given that miR-34a transcripts were increased in WT BMDMs
stimulated with TNF-a, they may contribute to the in vivo meta-
bolic profile. Therefore, using FACS we gated on the larger, more
granular F4/801 cells from WT and 34a2/2 eWAT to identify mac-
rophages, after 24 weeks on chow or HFD (Figure 4A). These cells
were CD451, CD11b1, MHCII1, and CD861. Further analysis
revealed a population of F4/80high cells within the miR-34a2/2
HFD group not observed in WT (Figure 4B). We observed a sig-
nificant increase in F4/80 surface expression on miR-34a2/2 cells,
when fed HFD (P 5 0.0497), and a lower F4/801 macrophage
content within the eWAT of miR-34a2/2 chow mice, compared
with WT chow (P 5 0.0078) (Figure 4C). There were no changes
in the other macrophage M1/M2 surface markers examined (Sup-
porting Information Figure S4A), or M1/M2 genes within the
eWAT, except a basal increase in miR-34a2/2 chow eWAT Nos2
(P 5 0.0500) and decreased HFD-fed miR-34a2/2 eWAT Retnla
(P 5 0.0006) transcripts, over WT diet controls (Supporting Infor-
mation Figure S4B). To check whether an increase in cytosolic
lipid could contribute to the F4/80high macrophage phenotype in
miR-34a2/2 HFD eWAT, we back-gated on this population for
side-scatter, a measurement of internal complexity, but observed
no difference in side-scatter MFI between any of the groups (Sup-
porting Information Figure S4C).
Bassaganya-Riera et al. identified a subset of F4/80high ATMs that
produced high levels of anti-inflammatory IL-10 (18). Therefore, we
examined eWAT cytokine transcripts and observed increased IL-10
in miR-34a2/2 HFD eWAT, compared with WT HFD and miR-
34a2/2 chow eWAT (P < 0.05) (Figure 4D). Additionally, serum
cytokine levels of IL-5 (P 5 0.0103) and chemokine CXCL9 (P 5
0.0303) were increased in HFD-fed miR-34a2/2 mice, over WT
controls (Figure 4E). However, serum IL-10 was not detected in any
group. miR-34a2/2 and WT in vitro BMDMs were stimulated with
TNF-a to assess macrophage-mediated modulation of metabolic and
inflammatory pathways. Interestingly, TNF-a stimulation of miR-
34a2/2 macrophages did not upregulate transcripts of the inflamma-
tory, neutrophil chemotactic cytokine Cxcl1 (P 5 0.0168), or
secreted protein (P 5 0.0470), as in WT controls (Figure 4F). As a
corollary, we observed a reduction in splenic neutrophil percentage
(CD451 CD11b1 F4/802 CD11c2 Ly6c-Ly6g1) in miR-34a2/2
mice from both chow (P 5 0.0003) and HFD (P 5 0.0356) groups,
compared with WT controls at week 24 of diet (Figure 4G). How-
ever, the same was not observed in the eWAT (Supporting Informa-
tion Figure S4D).
Examination of Cd36, Hmgcr, Lxra, Ppar-c, Fasn, and Acc-a tran-
scripts in BMDMs revealed no change (Supporting Information Fig-
ure S4E, F). However, higher basal transcript expression of Pgc1a
(P 5 0.0024) was observed in miR-34a2/2 BMDMs, which
decreased to WT levels upon TNF-a stimulation (P 5 0.0139) (Fig-
ure 4H). Additionally, other serum and BMDM supernatant cyto-
kines from miR-34a2/2 and WT mice did not change (Supporting
Information Figure S5).
In vitro miR-34a2/2 adipocytes showed changes
in lipid content
To examine the function of miR-34a in adipose tissue, we differenti-
ated primary white and brown adipocytes in vitro. We observed sig-
nificant upregulation of miR-34a transcripts (P 5 0.0330) by day 8
of differentiation in WT white adipocyte precursors (Figure 5A),
with upregulation of miR-34b* and 34c* at day 4 (P < 0.05), which
decreased by day 8 (Supporting Information Figure S6A).
Therefore, we examined differentiation genes in WT and miR-34a2/2
white adipocytes. Examination of Cebpa, Ppar-c, and Fabp4 over
the 8-day differentiation revealed only a small increase in Cebpa
Figure 3 Altered expression of metabolic genes in epididymal (e)WAT and intrascapular (i)BAT of miR-34a2/2 mice. (A,B) RT-qPCR data of metabolic gene
expression in eWAT and iBAT from WT and miR-34a2/2 (KO) mice after 24 weeks on chow vs. high-fat diet (HFD), normalized to 18s rRNA; n 5 6 for all
groups, except n 5 5 for KO HFD. All graphs represented as relative quantification (RQ) with RQmin2RQmax values. *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001, one-way ANOVA, with Bonferroni’s multiple comparisons post-test.
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expression (P 5 0.0396) at day 2 in miR-34a2/2 adipocytes (Figure
5B–D). Interestingly, we observed increased lipid content in day 8
miR-34a2/2 white adipocytes (P 5 0.0280) (Figure 5E) by FACS,
with no change in the percentage of lipid-positive cells (Figure 5F).
Surprisingly, miR-34a2/2 white adipocytes had increased superna-
tant leptin at day 0 (P 5 0.0458), with lower levels at day 6 (P 5
0.0009) of differentiation, compared with WT (Figure 5G). Further-
more, supernatant insulin was decreased at day 2 (P 5 0.0041) of
Figure 4 High-fat diet (HFD) -fed miR-34a2/2 mice show an F4/80high phenotype, with increased type 2 cytokines and a reduction in splenic neutro-
phils. (A) Representative dot-plots showing the gating strategy used to identify macrophages in the SVF from murine epididymal (e)WAT at week 24 in
WT and miR-34a2/2 (KO) mice on chow vs. HFD. (B) Representative dot-plots showing the F4/80high macrophage phenotype in KO eWAT after HFD
feeding, from the same study as panel A. (C) Quantification of panel B, showing median fluorescence intensity (MFI) values representing surface
expression and percentage F4/801 cells in the macrophage FSC-SSC gate; n 5 9 for all groups, except n 5 10 for KO chow. (D) RT-qPCR data of
interleukin (IL)-10 gene expression in eWAT from same study as panel A, normalized to 18s rRNA; n 5 6 for all groups, except n 5 5 for KO HFD
and WT chow. (E) Significant changes from cytokine Luminex data of serum from mice fasted for 16 to 18 h from the same study as panel A; n 5 6
for KO chow and WT HFD groups and n 5 5 for WT chow and KO HFD groups. (F) RT-qPCR gene expression and supernatant, cytokine Luminex
protein data for CXCL1, from WT and KO in vitro bone marrow-derived macrophages (BMDM)645.45 ng/mL tumor necrosis factor (TNF)-a for 24 h;
n 5 3. RT-qPCR data normalized to 18s rRNA. (G) FACS quantification of the percentage of neutrophils (CD451 CD11b1 F4/802 CD11c2Ly6c-
Ly6g1) in the FSC-SSC population from spleens of mice in the same study as panel A. Gating strategy is shown in Supporting Information Figure
S4D; n 5 8 for all groups, except n 5 4 for WT chow and n 5 6 for WT HFD. (H) RT-qPCR quantification of peroxisome proliferator-activated recep-
tor-y coactivator (PGC)-1a and c/ebpa transcripts in the same samples as panel F; n 5 3. All graphs represent mean values with SEM, except for RT-
qPCR, represented as relative quantification (RQ) with RQmin2RQmax values. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA, with Bonferroni’s
multiple comparisons post-test.
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Figure 5 miR-34a increases over in vitro white adipocyte differentiation, and miR-34a2/2 white adipocytes show increased lipid
content at day 8. (A) RT-qPCR quantification of miR-34a transcripts over in vitro differentiation of SVF white preadipocytes (day 0–
8) from WT murine epididymal (e)WAT, with mature adipocyte fraction (WAT) as a positive control, normalized to RNU6B; three
mice were pooled together for each replicate of n 5 3. (B–D) RT-qPCR gene expression over in vitro differentiation of SVF white
preadipocytes (day 0–8) from miR-34a2/2 (KO) and WT murine eWAT, with mature adipocyte fraction (WAT) as a positive control,
normalized to 18s rRNA; three mice were pooled together for each replicate of n 5 3. (E,F) Quantification of lipid in day 8 in vitro
adipocytes by FACS and BODIPY, represented as geometric mean fluorescence intensity (MFI) values representing content, and
percentage positive cells; n 5 3. (G,H) Adipokine Luminex measurements of leptin and insulin from supernatants of cultures in
panels B-D; n 5 3. All graphs represent mean values with SEM, except for RT-qPCR, represented as 1/DCt. Statistics were calcu-
lated using a two-way ANOVA, with Bonferroni’s multiple comparisons post-test, or an unpaired Student’s t-test for FACS lipid
measurements. A one-way ANOVA and Dunnett’s multiple comparisons post-test was used to calculate statistics for panel A,
compared with day 0. *P < 0.05, **P < 0.01, ***P < 0.001.
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miR-34a2/2 white adipocyte differentiation, compared with WT
(Figure 5H). We observed no change in resistin (Supporting Infor-
mation Figure S6B). In day 8 brown adipocytes, we did not observe
any changes in leptin, insulin, or resistin (Supporting Information
Figure S6C). Additionally, obesity proteome array analysis of day 8
supernatants from white and brown adipocyte cultures did not reveal
any other cytokine or adipokine differences (Supporting Information
Figure S7).
Figure 6.
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To further explore the metabolic changes in miR-34a2/2 iBAT, we
examined miR-34a expression over in vitro differentiation of WT
brown adipocyte precursors, but found no change in miR-34a
(Figure 6A). However, we observed increases in miR-34b* at day 4
(P 5 0.0305) and both miR-34b* and 34c* at day 6 (P < 0.05) and
day 8 (P < 0.01) of differentiation (Figure 6B).
WT and miR-34a2/2 day 8 brown adipocytes were stimulated with
noradrenaline to examine the effect of b-adrenergic stimulation on
Ucp1 and Pgc1a transcripts. However, we observed no difference in
Ucp1 and Pgc1a transcript expression (Figure 6C, D). Additionally,
we quantified cellular mitochondrial content by FACS but found no
difference (Figure 6E, F). However, FACS analysis identified an
increase in the percentage of noradrenaline-stimulated, miR-34a2/2
lipid-positive brown adipocytes (P 5 0.0445) (Figure 6G), with no
difference in cellular lipid content (Figure 6H).
We examined the expression of key brown adipocyte differentiation
genes, but found no difference in Pgc1a, Ucp1, Cebpa, Cebpb, or
Ppar-c transcripts between WT and miR-34a2/2 brown adipocytes
(Supporting Information Figure S8A). Finally, we observed no
change in white adipocyte Cd36, Hmgcr, Lxra, Pgc1a, Fasn, and
Acc-a metabolic genes (Supporting Information Figure S8B).
Discussion
The regulation of chronic, low-grade inflammation of adipose tissue
during obesity is poorly understood and this study aimed to address
the role of miR-34a in this process. Our findings showed that miR-
34a2/2 mice were heavier than WT controls and gained more
weight when challenged with a HFD, suggesting they were more
susceptible to weight gain. miR-34a2/2 eWAT showed smaller,
more numerous adipocytes, with a lower tissue mass on chow that
increased to WT levels on HFD. It is surprising that there was no
difference in these characteristics between HFD-fed miR-34a2/2 and
WT mice, despite a clear difference in body weight. With no change
in liver weight, this could suggest increases in other WAT depots
(e.g., scWAT), BAT, or muscle tissue. One gene that was increased
in all the miR-34a2/2 tissues examined was Pgc1a, suggesting that
it could have broad regulation by miR-34a. During preparation of
this article, Fu et al. showed that miR-34a could increase acetylation
of PGC1a, decreasing its activation, by inhibiting SIRT1 activity
and FGF21 signaling in HFD-fed murine eWAT and 3T3L1 adipo-
cytes, promoting adipose browning (19). Correlating with our
results, the authors observed increased transcripts of Pgc1a in
eWAT and BAT after lentiviral-mediated inhibition of miR-34a in
WAT and BAT of male, HFD-fed BALB/c and C57BL/6 mice.
However, they also observed a reduction in body weight, and vis-
ceral (epididymal and peritoneal) and scWAT, with improved glu-
cose tolerance. Earlier studies have also shown anti-miR-34a admin-
istration to HFD-fed mice improved systemic glucose and insulin
tolerance, and liver phenotype (20,21). All these studies used acute
miR-34a inhibition in established murine obesity, which is milder
than the 24-week HFD feeding used here. These differences with
our model are likely due to compensatory effects of using a full-
body KO. It seems paradoxical that miR-34a ablation causes an
upregulation in Pgc1a transcripts, but at the same time promotes
weight gain. However, full-body Pgc1a KO mice were shown to
lose weight, rather than gain weight as expected, and skeletal
muscle-specific murine Pgc1a overexpression (MPGC-1a TG)
caused muscle adipose accumulation, atrophy, and decreased ATP
synthesis and content, indicative of mitochondrial respiratory uncou-
pling (22,23).
Respiratory uncoupling by UCPs has been linked to increased FA
oxidation (24). It may seem counterproductive that in miR-34a2/2
eWAT we saw basal increases in genes involved in lipid uptake:
Cd36, de novo lipogenesis: Fasn, and cholesterol biosynthesis:
Hmgcr, which caused increases in adipocyte total and free choles-
terol, associated with omental adipocyte hypertrophy in primates
(25-27). However, MPGC-1a TGs have increased expression of
Cd36 and Fasn, with Fasn expression driven by PGC1a’s increase
in Lxra expression, and increased intracellular lipid (28). The
authors suggest that this response “refuels” the cell’s lipid stores for
continued FA oxidation. Therefore, there may be an imbalance in
lipolysis/FA oxidation vs. lipid uptake/lipogenesis, pushing metabo-
lism to the latter in adipocytes of miR-34a2/2 mice, due to chronic
PGC1a upregulation, which predisposes these mice to weight gain
when stressed with a HFD. Additionally, this would explain why
miR-34a2/2 mice are heavier before HFD feeding. In fact, when
MPGC-1a TGs were fed HFD they developed insulin resistance and
were not protected from diet-induced obesity, showing increased
lipid uptake and lipogenesis genes in skeletal muscle, including
Cd36, and no change in resting serum insulin, triglycerides, choles-
terol, glucose, and FFAs (29). The increased lipid content observed
in mature in vitro miR-34a2/2 white adipocytes supports this
Figure 6 In vitro miR-34a2/2 brown adipocytes show an increase in percentage lipid1 cells but no change in mitochondrial markers. (A,B) RT-qPCR
quantification of miR-34a, 34b*, and 34c* over in vitro WT brown adipocyte differentiation (day 0–8) from intrascapular (i)BAT SVF precursors, normalized
to RNU6B; three mice were pooled together for each replicate, n 5 3–4. (C,D) RT-qPCR gene expression at day 8 of in vitro differentiation of SVF brown
preadipocytes from miR-34a2/2 (KO) and WT murine iBAT, after a 4-h stimulation with 0.1 mM noradrenaline (NA) or PBS control, normalized to 18s
rRNA; three mice were pooled together for each replicate, n 5 4. (E,F) Quantification of mitochondria in day 8 in vitro brown adipocytes stimulated with
0.1 mM NA or PBS for 4 h, by FACS and MitroTracker Deep Red, shown as geometric mean fluorescence intensity (MFI) values representing content, and
percentage positive cells; n 5 3. (G,H) Quantification of lipid in day 8 in vitro brown adipocytes stimulated with 0.1 mM NA or PBS for 20 h, by FACS and
BODIPY, shown as geometric MFI values representing content, and percentage positive cells; n 5 3. All graphs represent mean values with SEM, except
for RT-qPCR, represented as 1/DCt. Statistics were calculated using a one-way ANOVA, with Bonferroni’s multiple comparisons post-test, or an unpaired
Student’s t-test for FACS measurements. *P < 0.05, **P < 0.01, ***P < 0.001. (I) A diagrammatic representation of the theoretical mechanism in miR-
34a2/2 (KO) mice, predisposing them to diet-induced obesity. The imbalance in WAT metabolic genes caused by chronic overexpression of peroxisome
proliferator-activated receptor-y coactivator (PGC)-1a and mitochondrial dysfunction promotes lipid uptake/storage and weight gain when stressed with a
high-fat diet (HFD). As the tissue increases in size there is an increase in inflammatory cytokines, such as tumor necrosis factor (TNF)-a, which polarize
macrophages to an M1 phenotype. However, the KO macrophages are unresponsive to TNF-a induction of CXCL1 and possibly other pro-M1 genes,
through overexpression of PGC1a inhibiting the NF-jB subunit p65, suggesting an M2 phenotype. This inhibits the recruitment of neutrophils which could
promote an M1 phenotype and inhibit lipogenic processes. The M2 phenotype is further promoted by interleukin (IL)-5, which can induce eosinophils to
produce pro-M2 IL-4. IL-10 likely produced by macrophages can then stimulate adipocytes to be more insulin sensitive and dampen inflammatory proc-
esses, reducing pro-obesity processes. Inhibition of key thermogenic genes in BAT predisposes the mice to obesity development, with overcompensation
by the induction of PGC1a during HFD feeding.
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metabolic imbalance. Additionally, the increase in miR-34a in WT
adipocytes over the time course of differentiation suggests that it
may regulate these processes in mature adipocytes, due to the lack
of change in differentiation makers in miR-34a2/2 white adipocytes.
The decreases in Ppar-c, Fasn, and Acc-a eWAT transcripts upon
HFD feeding in miR-34a2/2 mice, could be evidence of the balance
being shifted back to FA oxidation to regain lipid homeostasis, by
other regulatory systems. This could be assisted by the upregulation
of Pgc-1a mRNA in HFD-fed miR-34a2/2 BAT, which could com-
pensate for the reduced c/ebpa and b mRNA. Both c/EBPa and b
transactivate UCP1, and c/EBPb is essential for brown adipocyte
differentiation and thermoregulation (30,31). Unfortunately, we did
not see these differences in vitro with b-adrenergic stimulation, but
other stimuli could be involved in vivo. Furthermore, PGC1a has
been shown to be a predicted target of miR-34a in humans, but not
mice, using miRWalk (32). Therefore, the in vivo phenotype of
miR-34a2/2 mice could be attributed to PGC1a being a direct target
of miR-34a or indirectly through SIRT1/FGF21.
Our study showed that miR-34a2/2 ATMs have an altered phenotype,
and deficiency in inflammatory TNF-a responses in vitro. Flow cyto-
metric analysis identified F4/80high CD451 MHCII1 CD11b1 CD861
macrophages within eWAT of HFD-fed miR-34a2/2 mice and a
reduced F4/801 macrophage population in chow-fed miR-34a2/2
mice. F4/80 is a glycoprotein specific for murine macrophages, with
expression increasing as macrophages mature, but its specific function
remains unknown. However, Lin et al. showed that F4/80 has a role in
generating CD81 regulatory T cells (33). F4/80high ATMs have previ-
ously been observed in murine WAT, but have been shown to be in
equal proportions F4/80low:F4/80high in obese db/db WAT and greater
proportions of F4/80high ATMs in diet-induced obese WAT (18,34).
Bassaganya-Riera et al. showed that these F4/80high ATMs expressed
higher levels of MHCII, CX3CR1, CD11c, CCR2, and PPAR-c in db/
db mice, with increased intracellular IL-6, TNF-a, CCL2, and IL-10,
which increased further upon LPS-stimulation (18). These reports sup-
port our observations of increased IL-10 mRNA in HFD-fed miR-
34a2/2 eWAT, correlating with the ATM F4/80high phenotype. The
increase in IL-10 suggests an M2-like phenotype. Corollary, the in
vitro data showing ablated upregulation of CXCL1 in TNF-a-
stimulated miR-34a2/2 BMDMs, suggests a deficiency in TNF-a sig-
naling. Additionally, the upregulation of miR-34a transcripts in TNF-
a-stimulated BMDMs, supports the possibility of miR-34a regulating
the TNF-a pathway. This has been previously suggested by Jiang et al.
with contradictory results using LPS-stimulated RAW264.7 macro-
phages, showing miR-34a inhibits TNF-a expression by targeting the
NF-jB p50-subunit activator NOTCH1 (12). However, we showed
that Pgc1a was upregulated in unstimulated miR-34a2/2 in vitro mac-
rophages, which others have shown represses TNF-a-induced proin-
flammatory cytokine production by reducing RelA/p65 phosphoryla-
tion, inhibiting NF-jB signalling in murine skeletal muscle (35).
Paradoxically, Bassaganya-Riera et al. suggested that F4/80high mac-
rophages are M1-like, despite expressing high levels of IL-10 and
PPAR-c. Furthermore, we observed a reduction in the M2 marker
Retnla in HFD-fed miR-34a2/2 eWAT and an increase in the M1
marker Nos2 in chow-fed miR-34a2/2 eWAT. Therefore, it is unclear
whether miR-34a2/2 macrophages have a pro- or anti-inflammatory
phenotype, but their phenotype could be altered by dysregulation of
PGC1a.
Systemically, we observed characteristics of a type 2 immune
response in miR-34a2/2 mice with increased serum IL-5 protein
during HFD feeding and a reduction in splenic neutrophils observed
in both miR-34a2/2 groups. Interestingly, neutrophil-specific elas-
tase KO mice have increased M2-like ATMs and increased tran-
scripts of Acc-a and Fasn within WAT (17). However, we did not
see the same decrease in eWAT neutrophils. Importantly, a type 2
immune response has been reported to promote increased insulin
sensitivity, glucose uptake, and anabolism in white adipocytes, but
an overall protective effect from obesity and T2D (16,36,37). There-
fore, a type 2 immune response in HFD-fed miR-34a2/2 mice may
be initiated as a compensatory effect during overnutrition, to regain
metabolic homeostasis. A study limitation is that we did not exam-
ine miR-34a expression in BMDMs from HFD-fed mice or TNF-a-
stimulated adipocytes.
In summary, this study has demonstrated that miR-34a regulates the
development of diet-induced obesity in mice, with miR-34a2/2 mice
showing a susceptibility to weight gain, likely through dysregulation
of PGC1a (Figure 6I). It is clear that the role of miR-34a in metabo-
lism is complex and likely to vary depending on context of treat-
ment and model, with potentially contrasting roles in different cell
types. miRNAs’ fine-tuning of gene expression results in subtle
changes in protein synthesis, making it complex to follow up in vivo
observations with complete mechanistic data in vitro, as seen here.
However, this study has highlighted that chronic miR-34a inhibition,
as a treatment for obesity, may have undesirable metabolic and
immunoregulatory consequences. Further research is required to
fully elucidate the metabolic and inflammatory pathways regulated
by miR-34a.O
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